AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 137 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,482,343 | -63.2% | 389,082 | -36.0% | 0.02% | -60.5% |
| Q2 2023 | $6,737,286 | +15.2% | 607,510 | +59.5% | 0.04% | -5.0% |
| Q1 2023 | $5,847,137 | -16.9% | 380,921 | +20.2% | 0.04% | -32.2% |
| Q4 2022 | $7,032,965 | +218.8% | 316,943 | +134.6% | 0.06% | +156.5% |
| Q3 2022 | $2,206,000 | +237.8% | 135,082 | +200.4% | 0.02% | +283.3% |
| Q2 2022 | $653,000 | -54.6% | 44,974 | -42.2% | 0.01% | -33.3% |
| Q1 2022 | $1,437,000 | -5.8% | 77,827 | +21.2% | 0.01% | +12.5% |
| Q4 2021 | $1,526,000 | +49.3% | 64,207 | +54.8% | 0.01% | +14.3% |
| Q3 2021 | $1,022,000 | -14.2% | 41,481 | -13.9% | 0.01% | -12.5% |
| Q2 2021 | $1,191,000 | -10.0% | 48,196 | -20.6% | 0.01% | -11.1% |
| Q1 2021 | $1,324,000 | – | 60,704 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
| COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
| 5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
| RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
| Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
| RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
| Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
| Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
| AtonRa Partners | 18,970 | $121,029 | 0.25% |
| Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |